4,0
29 dic 2021
Dipendente attuale
Basel, Basel-City
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Good company and more flexible and agile than most bigger pharma or medical device companies
Svantaggi
Still old structures that need shaking up